We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Florida Compounders Issued Warning Letters and Urged to Assess Operations
Two Florida Compounders Issued Warning Letters and Urged to Assess Operations
The FDA is urging two Florida compounders to reassess their operations after finding significant issues with GMPs and sterile drug practices during inspections.